	TIPE3 in Cancer: A Multifaceted Regulator of Tumorigenesis, Therapeutic Resistance, and Clinical Outcomes. Technol Cancer Res Treat Zhang Y, Cao H, Yu D, Feng W, Cao S, Zhou Y, Lau KS, Li Z. PMID: 42299458 [PubMed - indexed for MEDLINE]
	Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium. Int J Cancer Worthington C, Raitses-Gurevich M, Innamorati G, Hart PA, Wilkie TM, Tau N, Brin D, Yablecovitch D, Laish I, Keith D, Giles K, Permuth JB, Simeone DM, Zogopoulos G, Brand RE, Graff JJ, Earl J, PRECEDE Consortium. PMID: 42298760 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol Frey MC, Lopez-Lopez V, Benz A, Abdurakhmonov S, Amirian H, Datta J, Lee SH, Yoo C, Pu N, Zhang C, Reames BN, Fritsch R, Petrowsky H, Oberholzer J, Eshmuminov D. PMID: 42298078 [PubMed - as supplied by publisher]
	Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials. Diabetes Obes Metab Chiang CH, Bahar F, Chang YC, Wang TH, Hsia YP, Chiang CH. PMID: 42297743 [PubMed - as supplied by publisher]
	Risk of pancreatic cancer associated with precursor lesions in individuals and first-degree relatives: a nationwide cohort study. Clin Gastroenterol Hepatol Ludvigsson JF, Sun J, Yuan C, Vujasinovic M, Löhr JM, Wolpin BM, Wang QL. PMID: 42297317 [PubMed - as supplied by publisher]
	Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma. JTO Clin Res Rep Kok PS, Chan B, Aberoumoud M, Zhang A, O'Byrne K, Thavaneswaran S, Lin F, Kansara M, Corpuz T, Wheeler P, Simes RJ, Thomas D, Lee CK. PMID: 42293288 [PubMed]
	LncRNA MIR22HG and miR-10a-5p: Pioneering serum biomarkers for pancreatic cancer diagnosis and progression assessment. Noncoding RNA Res Salman RM, Radwan AF, Shaker OG, El-Husseiny AA. PMID: 42293029 [PubMed]
	Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma. Front Immunol Wang Z, Tang J, Zhu S, Li S, Yao B, Tu J, Zhou X, Tang Q, Zhong L. PMID: 42292467 [PubMed - indexed for MEDLINE]
	The life cycle of tertiary lymphoid structures in pancreatic cancer-a window of opportunity for immunotherapy. Front Immunol Chen Y, Xiao Y, Zhang T, Wang X. PMID: 42292349 [PubMed - indexed for MEDLINE]
	Nimotuzumab combined with gemcitabine and nab-paclitaxel as first-line therapy for advanced pancreatic cancer: a single-arm, single-center Phase II prospective study. Front Med (Lausanne) Lin L, Zhao X, Luo Y, Cai JH, Lin Z, Xiao L, Tian G, He S. PMID: 42292240 [PubMed]
	Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy. iScience Pan Z, Zhang F, Zhang C, Li X, Ma Y, Yang Y, Tian X. PMID: 42291273 [PubMed]
	Natural Products and Long Noncoding RNAs: A Complex Regulatory Network in Pancreatic Cancer Progression and Treatment. J Biochem Mol Toxicol Elimam H, Radwan AF, Elfar N, Ghaiad HR, Abd-Elmawla MA, Zaki MB, Nassar K, Mohammed OA, Doghish AS. PMID: 42290329 [PubMed - indexed for MEDLINE]
	Central Pancreatectomy with Duct-to-Mucosa Pancreaticogastrostomy Using a Knotless Continuous Suturing Technique: Initial Experience with a Totally Laparoscopic Approach. Asian J Endosc Surg Kawashima M, Matsushita A, Hamaguchi A, Kato Y, Ono T, Irie T, Ga R, Aoki Y, Oshiro Y, Nakamura Y. PMID: 42289762 [PubMed - indexed for MEDLINE]
	Study on the inhibition of liver cancer progression by lenvatinib nanoparticles combined with hyaluronic acid/gelatin scaffold. Colloids Surf B Biointerfaces Zhu L, Chen H, Guo Q, Ren C, Shi P, Wang Q, Hu Y, Fan Z, Xu Y, Lin D, Chen H. PMID: 42287829 [PubMed - as supplied by publisher]
	6-mm versus 10-mm covered self-expandable metal stents and plastic stents for malignant distal biliary obstruction in resectable or borderline resectable pancreatic cancer in Japan (STARDOM, JON-2402P): study protocol for a multicenter randomized controlled trial. Trials Yamashige D, Hijioka S, Yasuda I, Hayashi N, Taguri M, Ueno M, Furuse J, Japan Oncology Network in Hepatobiliary and Pancreas. PMID: 42286634 [PubMed - as supplied by publisher]
	Intraductal Papillary Mucinous Neoplasm Worsening Glycemic Control in a Patient with Type 2 Diabetes Mellitus. Am J Med Sci Varghese RT, Ayar UD, Zamin MR, Oyalade FK, Valencia VC, Aoun ML. PMID: 42285223 [PubMed - as supplied by publisher]
	Health-related quality of life among patients with colorectal und pancreatic cancer: results from a monocentric registry study. Gesundheitswesen Piontek D, Schoffer O, Datzmann T, Boehme H, Distler M, Fritzmann J, Hempel S, Oehme F, Radulova-Mauersberger O, Ubbelohde U, Bornhaeuser M, Weitz J, Schmitt J. PMID: 42285169 [PubMed - as supplied by publisher]
	Clinicopathological features of pancreatic solid pseudopapillary neoplasm: A retrospective single-center study of 32 cases in Guangzhou, China. Pathol Res Pract Quan S, Li G, Liu S, Wu J, He P, Hu J. PMID: 42284974 [PubMed - as supplied by publisher]
	Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. Cell Rep Shrivastava A, Pederson EN, Nguyen TU, Chuen J, Mohan P, Pande S, Toribio AR, Lecomte N, Melchor J, McAuliffe JC, Grandgenett PM, Rajasekhar VK, Nishikawa K, Knörlein A, David Y, Willis IM, Iacobuzio-Donahue CA, Ouyang Z, Singh K. PMID: 42284146 [PubMed - as supplied by publisher]
	CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B-Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation. Hum Mutat Jiang Z, Ma P, Zhang S, Jin Z, Wang Y, Zhou Y, Zhu Q, Lu C, Tu N, Zhang ZA, Mou Y, Jin W. PMID: 42282992 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 60441

Page 1 of 3023



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy